| Identification | Back Directory | [Name]
trans-6A,7,8,10A-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(B,D)pyran-1-ol | [CAS]
6465-30-1 | [Synonyms]
(±)-δ9-THC (For Qualitative Use Only)
Heptane ( test (±)-Δ9-THC (For Qualitative Use Only)100 μg/mL)
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol
trans-6A,7,8,10A-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(B,D)pyran-1-ol
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-rel- | [EINECS(EC#)]
804-125-9 | [Molecular Formula]
C21H30O2 | [MOL File]
6465-30-1.mol | [Molecular Weight]
314.46 |
| Chemical Properties | Back Directory | [Boiling point ]
390.4±42.0 °C(Predicted) | [density ]
1.015±0.06 g/cm3(Predicted) | [Fp ]
-4℃ | [storage temp. ]
-20°C | [solubility ]
Acetonitrile: 50 mg/ml | [pka]
9.81±0.60(Predicted) |
| Hazard Information | Back Directory | [Description]
(±)-Δ9-THC (exempt preparation) (Item No. 34629) is an analytical reference standard categorized as a racemic mixture of the phytocannabinoid (−)-Δ9-THC and the synthetic cannabinoid (+)-Δ9-THC.1 (−)-Δ9-THC is the primary psychoactive component of Cannabis. (+)-Δ9-THC also has psychoactive properties. (±)-Δ9-THC is regulated as a Schedule I compound in the United States. (±)-Δ9-THC (exempt preparation) (Item No. 34629) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | [Description]
(±)-Δ9-THC (Item No. 9003740) is an analytical reference standard categorized as a racemic mixture of the phytocannabinoid (−)-Δ9-THC and the synthetic cannabinoid (+)-Δ9-THC.1 (−)-Δ9-THC is the primary psychoactive component of Cannabis. (+)-Δ9-THC also has psychoactive properties. (±)-Δ9-THC is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. | [Definition]
ChEBI: Delta(9)-tetrahydrocannabinol is a diterpenoid that is 6a,7,8,10a-tetrahydro-6H-benzo[c]chromene substituted at position 1 by a hydroxy group, positions 6, 6 and 9 by methyl groups and at position 3 by a pentyl group. The principal psychoactive constituent of the cannabis plant, it is used for treatment of anorexia associated with AIDS as well as nausea and vomiting associated with cancer chemotherapy. It has a role as a metabolite, a non-narcotic analgesic, a hallucinogen, a cannabinoid receptor agonist and an epitope. It is a diterpenoid, a benzochromene, a polyketide and a phytocannabinoid. | [References]
[1] BILLY R. MARTIN. Behavioral comparisons of the stereoisomers of tetrahydrocannabinols[J]. Life sciences, 1981, 29 6: Pages 565-574. DOI: 10.1016/0024-3205(81)90434-3 |
|
|